Health
Australian firm says its nasal spray reduced coronavirus growth in animal study – The Tribune
Ena Respiratory ready to test INNA-051 in human trials in less than four months
Sydney, September 28
Australian biotech company Ena Respiratory said on Monday that a nasal spray it is developing to improve the human immune system to fight common cold and flu significantly reduced the growth of the coronavirus in a recent study on animals.
A study on ferrets showed the product dubbed INNA-051, which could be used complementary to vaccines, lowered the levels of the virus that causes COVID-19 by up to 96%, the company said.
The study was led by British government agency Pu…
-
Noosa News23 hours agoQueensland weather forecast sees sunny weather for last week of winter
-
Business21 hours agoWhy the Betashares Nasdaq 100 ETF could be a perfect buy and hold pick
-
Business22 hours agoDoes Macquarie rate BHP shares a buy after its FY25 results?
-
General17 hours agoMigrants raise concerns over Australia’s English tests for visa applicants